Prelude Therapeutics Inc Stock Components

Prelude Therapeutics Inc Stock Components - Investing.com

Prelude Therapeutics Inc (PRLD) · Overview · Profile · Historical Data · Options · Index Component ...

Prelude Therapeutics Incorporated (PRLD) - Yahoo Finance

Compare To: PRLD ; PRLD. Prelude Therapeutics Incorporated. 1.0400 ; FHTX. Foghorn Therapeutics Inc. 8.01 ; SPRB. Spruce Biosciences, Inc. 0.4906.

Stock Quotes & Charts - Investor Relations - Prelude Therapeutics

We are focused on the rapid design and development of new medicines based on breakthroughs in cancer research.

Prelude Therapeutics Incorporated Common Stock (PRLD) - Nasdaq

Discover real-time Prelude Therapeutics Incorporated Common Stock (PRLD) stock prices, quotes, historical data, news, and Insights for informed trading and ...

PRLD: Prelude Therapeutics Inc - Stock Price, Quote and News

Get Prelude Therapeutics Inc (PRLD:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

SEC Filing - Investor Relations - Prelude Therapeutics

and Zentalis Pharmaceuticals, Inc., are developing precision oncology medicines. ... company through stock option grants and our employee stock purchase plan. We ...

S-1 - SEC.gov

... company,” “we,” “us” and “our” in this prospectus to refer to Prelude Therapeutics Incorporated. Overview. We are a clinical-stage precision oncology company ...

Prelude Therapeutics Company Profile 2024 - PitchBook

The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and ...

Prelude Therapeutics Inc Stock Price Today | NASDAQ: PRLD Live

Prelude Therapeutics Incorporated, a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel precision cancer medicines.

Prelude Therapeutics Incorporated Registered Shs - Stock - , PRLD

Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the ...

Prelude Therapeutics Incorporated Common Stock (PRLD) Analyst ...

Find the latest analyst research, reports, and ratings for Prelude Therapeutics Incorporated Common Stock (PRLD) at Nasdaq.com.

SEC Filing - Investor Relations - Prelude Therapeutics

... shares of common stock at a price of $5.7499 per pre-funded warrant. The Baker Funds purchased 1,448,222 shares of the Company's non-voting common stock and ...

Prelude Therapeutics Inc. Stock Quote (U.S. - PRLD - MarketWatch

Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the ...

Form 10-Q for Prelude Therapeutics INC filed 08/12/2024

accumulated other comprehensive loss, a component of stockholders' equity. Realized gains and losses as well as credit losses, if any, on ...

PRLD - Prelude Therapeutics Stock Price - Barchart.com

Prelude Therapeutics Incorporated is a clinical-stage precision oncology company. It is focused on discovering and developing small molecule therapies ...

PRLD - Prelude Therapeutics Incorporated Stock - Fintel

Prelude Therapeutics Incorporated (NasdaqGS:PRLD) institutional ownership structure shows current positions in the company by institutions and funds, as well as ...

Prelude Therapeutics Stock Price History - Macroaxis

The current year's Issuance Of Capital Stock is expected to grow to about 124.1 M, whereas Total Stockholder Equity is forecasted to decline to about 157.4 M. .

SEC Filing - Investor Relations - Prelude Therapeutics

... Pharmaceuticals, Inc., Eli Lilly and Company, F. Hoffman-La Roche ... company through stock option grants and our employee stock purchase plan. We ...

Prelude Therapeutics Inc (PRLD) - Valuation Measures & Financial ...

Prelude Therapeutics Inc. NAS:PRLD (USA) Ordinary Shares. $ 1.32 +0.025 (+1.94 ... Components · Inventories, Work In Process · Investments And Advances · Land ...

PRLD | Prelude Therapeutics Incorporated Stock Data, Price & News

Prelude Therapeutics Incorporated · Patent Title: Cdk inhibitors and their use as pharmaceuticals Oct. · Patent Title: Cdk inhibitors and their use as ...